Follow

Submissions from 2011

Link

Resolute™ drug-eluting stent: a resolution for bifurcation lesions?, R. Jermyn and L. Gruberg

Link

Statin effect on thrombin inhibitor effectiveness during percutaneous coronary intervention: A post-hoc analysis from the ISAR-REACT 3 trial, A. A. Khattab, G. Ndrepepa, S. Schulz, F. J. Neumann, J. Mehilli, H. J. Büttner, J. Pache, M. Seyfarth, P. B. Berger, G. Richardt, and +3 additional authors

Statin therapy in the perioperative period, J. S. Lander and N. L. Coplan

Link

Peripheral artery disease. Part 1: Clinical evaluation and noninvasive diagnosis, J. F. Lau, M. D. Weinberg, and J. W. Olin

Link

Letter by maytin and epstein et al regarding article, complications associated with revision of sprint fidelis leads: Report from the canadian heart rhythm society device advisory committee, M. Maytin and L. M. Epstein

Should every broken lead be extracted?, M. Maytin and L. M. Epstein

Link

The challenges of transvenous lead extraction, M. Maytin and L. M. Epstein

Link

Lead implant duration does not always predict ease of extraction: Extraction sheath may be required at < 1 year, M. Maytin, L. M. Epstein, and R. M. John

Link

Reply to: Multicenter Experience With Extraction of the Sprint Fidelis Implantable Cardioverter-Defibrillator Lead, M. Maytin, C. J. Love, A. Fischer, R. G. Carrillo, J. D. Garisto, M. G. Bongiorni, L. Segreti, R. M. John, G. F. Michaud, L. M. Epstein, and +1 additional author

Link

Recurrent cardiovascular events with paclitaxel-eluting versus bare-metal stents in saphenous vein graft lesions: Insights from the sos (stenting of saphenous vein grafts) trial, T. T. Michael, A. R. R. Abdel-Karim, A. Papayannis, C. Lichtenwalter, J. A. De Lemos, O. Obel, T. Addo, M. Roesle, P. B. Berger, E. S. Brilakis, and +11 additional authors

Link

Signs and symptoms of suspected myocardial ischemia in women: Results from the what is the optimal method for ischemia evaluation in women? Trial, J. H. Mieres, G. V. Heller, R. C. Hendel, M. Gulati, W. E. Boden, D. Katten, and L. J. Shaw

Link

Reversal of outflow tract ventricular premature depolarizationinduced cardiomyopathy with ablation: Effect of residual arrhythmia burden and preexisting cardiomyopathy on outcome, S. E. Mountantonakis, D. S. Frankel, E. P. Gerstenfeld, S. Dixit, D. Lin, M. D. Hutchinson, M. Riley, R. Bala, J. Cooper, F. E. Marchlinski, and +3 additional authors

Link

Indications for implantable cardioverter-defibrillator placement in ischemic cardiomyopathy and after myocardial infarction, S. E. Mountantonakis and M. D. Hutchinson

PDF

Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction - REVEAL: A randomized controlled trial, S. S. Najjar, S. V. Rao, C. Melloni, S. V. Raman, T. J. Povsic, L. Melton, G. W. Barsness, K. Prather, L. Gruberg, R. A. Harrington, and +10 additional authors

Link

Providing high-value, cost-conscious care, I. S. Nash

PDF

Management of hypertension among patients with coronary heart disease, O. Olafiranye, F. Zizi, P. Brimah, G. Jean-Louis, A. N. Makaryus, S. McFarlane, and G. Ogedegbe

Link

Pulmonary Doppler signals: A potentially new diagnostic tool, Y. Palti, A. Kanter, E. Solter, R. Schatzberger, and I. Kronzon

Link

Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: A time-dependent analysis of the gauging responsiveness with a verifynow P2Y12 assay: Impact on thrombosis and safety (GRAVITAS) trial, M. J. Price, D. J. Angiolillo, P. S. Teirstein, E. Lillie, S. V. Manoukian, P. B. Berger, J. F. Tanguay, C. P. Cannon, and E. J. Topol

Link

Patient blood management during cardiac surgery: Do we have enough evidence for clinical practice?, M. Ranucci, S. Aronson, W. Dietrich, C. M. Dyke, A. Hofmann, K. Karkouti, M. Levi, G. J. Murphy, L. Shore-Lesserson, C. Von Heymann, and +1 additional author

Link

Resetting criteria during ventricular overdrive pacing successfully differentiate orthodromic reentrant tachycardia from atrioventricular nodal reentrant tachycardia despite interobserver disagreement concerning QRS fusion, J. Z. Rosman, R. M. John, W. G. Stevenson, L. M. Epstein, U. B. Tedrow, B. A. Koplan, C. M. Albert, and G. F. Michaud

Link

Bisphosphonate-related osteonecrosis of the jaw: An overview, S. L. Ruggiero

Link

Use of low-dose heparin with bivalirudin for ad-hoc transradial coronary interventions: Experience from a single center, A. Singh, D. Edasery, A. Noor, N. Bhasin, B. Kaplan, and R. Jauhar

PDF

Noninvasive ventilation in acute respiratory failure due to H1N1 influenza: A word of caution, A. Singh and J. Singh

Link

Neuroleptic malignant syndrome with metoclopramide overdose coexisting with Clostridium difficile diarrhea, A. Supariwala, G. Kant, and R. E. Jean

Link

Synergistic effect of coronary artery disease risk factors on long-term survival in patients with normal exercise SPECT studies, A. Supariwala, S. Uretsky, P. Singh, S. Memon, S. S. Khokhar, O. Wever-Pinzon, P. Atluri, J. Hersh, H. K. Koppuravuri, and A. Rozanski

Link

Outcomes of cardiac perforation complicating catheter ablation of ventricular arrhythmias, M. Tokuda, P. Kojodjojo, L. M. Epstein, B. A. Koplan, G. F. Michaud, U. B. Tedrow, W. G. Stevenson, and R. M. John

Link

Transcoronary ethanol ablation for recurrent ventricular tachycardia after failed catheter ablation: An update, M. Tokuda, P. Sobieszczyk, A. C. Eisenhauer, P. Kojodjojo, K. Inada, B. A. Koplan, G. F. Michaud, R. M. John, L. M. Epstein, U. B. Tedrow, and +2 additional authors

Link

Role of real-time three dimensional echocardiography in cardiovascular interventions, W. Tsang, R. M. Lang, and I. Kronzon

Link

Three-dimensional echocardiography in the assessment of prosthetic valves, W. Tsang, L. Weinert, I. Kronzon, and R. M. Lang

Link

The 4-valve view, M. Vitellas, I. Kronzon, C. Barnes, and G. Perk

Link

Peripheral artery disease. Part 2: Medical and endovascular treatment, M. D. Weinberg, J. F. Lau, K. Rosenfield, and J. W. Olin

Link

Intraluminal thrombus in facilitated versus primary percutaneous coronary intervention: An angiographic substudy of the ASSENT-4 PCI (assessment of the safety and efficacy of a new treatment strategy with percutaneous coronary intervention) trial, J. Zalewski, K. Bogaerts, W. Desmet, P. Sinnaeve, P. Berger, C. Grines, T. Danays, P. Armstrong, and F. Van De Werf